Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KHK6640 Phase 1 Study in Japanese Patients with Alzheimer's Disease
jRCT2080223486Phase 1
- Sponsor
- Kyowa Kirin
- Start
- Mar 2017
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics, Peptides
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in Alzheimer's disease (AD) comparing KHK6640 with Placebo (2 arms).
02
Drugs
KHK6640
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on jRCT2080223486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223486.